SignPost is building the BreastDefense Intelligence Engine for Breast Cancer.
An AI powered system for early detection, phenotype insight, and disease trajectory modeling over time.
Cancer care today suffers from a timing problem. Diagnostics typically rely on single signals at a moment in time, creating snapshots that often miss the true underlying biology of the disease.
By shifting the industry’s focus from traditional wet-lab interpretation to advanced computational modeling, integrating 29 million biomarkers and full gene mapping, we are modeling disease states over time for the first time in human history.
